Prostate cancer Board decisions

The Board has determined that the Veteran does not have a current diagnosis of any claimed conditions and finds no evidence to support service connection for these disabilities.

The Veteran's prostate cancer residuals are granted a 60 percent rating since March 3, 2015. The claim for service connection for hearing loss and tinnitus was previously granted.

The Veteran's prostate cancer residuals are rated at 40 percent since June 22, 2015. The Veteran is denied a higher rating for his prostate cancer and TDIU prior to July 21, 2011.

Service connection for prostate cancer is granted due to presumed exposure to herbicides in Thailand. Service connection for colon polyps and macular degeneration of the left eye are remanded.

The Veteran's prostate cancer, presumed due to herbicide exposure in Thailand, is granted service connection.,Erectile dysfunction and urinary dysfunction are secondary to the newly granted prostate cancer.

The Board has remanded the case due to insufficient medical opinions regarding whether the Veteran's service-connected prostate cancer and related symptoms were the cause of his fatal motor vehicle accident.

The Veteran's prostate cancer is granted service connection as it is presumed to be due to his in-service exposure to herbicide agents, specifically Agent Orange used at Korat Royal Thai Air Force Base.

The Veteran's service-connected disabilities rendered him unable to secure and follow any form of substantially gainful employment prior to March 14, 2016. Basic eligibility for Dependents' Educational Assistance under 38 U.S.C. Chapter 35 is also established.

The Board has determined that the issues of a separate rating for prostate cancer residuals on the basis of bowel incontinence and TDIU prior to September 26, 2014 are inextricably intertwined. These matters are REMANDED.

The Board has granted service connection for diabetes mellitus, type 2, prostate cancer, and hypertension. The Veteran's peripheral neuropathy of the bilateral upper and lower extremities and erectile dysfunction are remanded due to a duty to assist error.

The Board has remanded the case due to unclear findings regarding the Veteran's prostate cancer and his ability to work.

The Board denied service connection for kidney cancer and prostate cancer, finding that the conditions are not related to service or any service-connected disability.

The Board denied service connection for prostate cancer, squamous cell cancer (SCC), and a colostomy. The cancers are considered secondary to the Veteran's prostate cancer, which is not service-connected due to lack of evidence linking it to his service or exposure to tactical herbicides.

The Veteran's appeal for restoration of a 100 percent rating for prostate cancer and a higher rating for residuals of prostate cancer is denied. The Veteran's prostate cancer was found to be in remission, with predominant residual dysfunction being voiding dysfunction.

The Veteran's prostate cancer and erectile dysfunction have been granted service connection with effective dates of December 10, 2018 for the prostate cancer and May 10, 2019 for the erectile dysfunction. The Veteran is also entitled to SMC based on loss of use of a creative organ as of May 10, 2019.

The Veteran's prostate cancer, ischemic heart disease, diabetes mellitus, type II, and bilateral peripheral neuropathy were denied service connection as they are not related to his active military service.,Service connection for the Veteran's prostate cancer was reopened due to new evidence provided.

The Board granted a TDIU on an extraschedular basis, and the appellant is entitled to attorney fees in full amount of 20 percent of past-due benefits awarded.

The Veteran's prostate cancer residuals are rated at 40 percent beginning October 1, 2019. The decision grants a higher rating than the current 10 percent for his service-connected prostate cancer.

The Veteran's prostate cancer is presumed to have been caused by herbicide agent exposure during his service in Vietnam. Service connection for prostate cancer is granted.

The Veteran's claims for coronary artery disease, congestive heart failure, prostate cancer, and prostatitis have been dismissed due to the death of the appellant.